Company intelligence / Profile preview

Applied Molecular Transport

South San Francisco, California, United Stateslinkedin.com ↗
Ownership
Public · AMTI
Employees
~13
Development stage
Phase 2
01

Overview

The lead program AMT‑101 completed four Phase 2 trials in ulcerative colitis. Results showed similar clinical remission rates between drug and placebo arms but demonstrated good tolerability. The second program, AMT‑126 targeting IL‑22 pathways for GI disorders, entered Phase 1a trials with plans for further development that were halted as part of strategic restructuring.

Therapeutic areas
GastroenterologyImmunology
Modalities
Oral biologics (proteins, peptides)Full-length antibodies and antibody fragmentsRNA therapeutics
Industry
Biotech
02

Drug pipeline

2 assets

AMT-101

Phase 2
Indications
Ulcerative colitis, Pouchitis, Inflammatory bowel disease

1 more asset in the full pipeline.

Request access →
03

Partnerships

Merger agreement with Cyclo Therapeutics Inc.; no other major disclosed partnerships pre-merger.
04

Financials

Market cap
$11M
Total revenue
$0
Enterprise value
$-5.7M

Beyond the preview

Go deeper on Applied Molecular Transport.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Applied Molecular Transport.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call